泓博医药 - Financials

泓博医药 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
+Revenue	544.0M	490.0M	479.0M	448.0M	283.0M	245.0M	126.0M	131.0M	107.0M	75.8M	77.8M	32.9M
Revenue Growth %	11.0%	2.3%	6.9%	58.3%	15.5%	94.4%	-3.8%	22.4%	41.1%	-2.5%	136.5%	--
Total Revenue	544.0M	490.0M	479.0M	448.0M	283.0M	245.0M	126.0M	131.0M	107.0M	75.8M	77.8M	32.9M
Cost Of Revenue	415.0M	339.0M	302.0M	275.0M	163.0M	146.0M	74.3M	69.0M	53.8M	34.7M	33.5M	17.7M
+Gross Profit	129.0M	151.0M	177.0M	173.0M	120.0M	99.0M	51.7M	62.0M	53.2M	41.1M	44.3M	15.1M
Gross Margin %	23.7%	30.8%	37.0%	38.6%	42.4%	40.4%	41.1%	47.3%	49.7%	54.2%	56.9%	46.0%
Total Operating Cost	554.0M	462.0M	411.0M	366.0M	233.0M	198.0M	119.0M	117.0M	95.3M	69.2M	66.6M	32.2M
Selling Expenses	13.9M	12.9M	8.1M	5.2M	4.1M	5.8M	3.9M	4.3M	4.5M	2.9M	2.7M	854,900
Admin Expenses	75.3M	60.7M	72.0M	57.7M	41.3M	30.4M	31.0M	29.5M	33.3M	30.1M	26.2M	13.1M
Rd Expenses	47.3M	37.3M	32.7M	17.1M	11.8M	10.6M	6.6M	7.8M	--	--	--	--
Finance Expenses	983,300	-584,600	-7.4M	4.6M	10.2M	155,700	997,000	2.7M	1.1M	1.2M	2.7M	443,400
+Operating Income	3.6M	37.4M	72.8M	86.7M	55.3M	51.1M	12.9M	15.4M	11.8M	6.9M	11.2M	684,900
Operating Margin %	0.7%	7.6%	15.2%	19.3%	19.5%	20.9%	10.2%	11.7%	11.1%	9.1%	14.3%	2.1%
Non Operating Income	189,100	26,300	205,700	56,900	275,900	1.6M	--	42,200	3.8M	1.5M	4.8M	2.2M
Non Operating Expenses	287,000	707,800	129,400	488,800	352,200	774,600	1.5M	516,400	92,000	25,100	50,600	8,800
Investment Income	3.4M	628,500	603,300	1.8M	1.7M	1.4M	2.0M	50,000	54,500	317,800	--	--
Fair Value Change Income	5.0M	5.6M	-99,400	397,700	--	270,900	--	--	--	--	--	--
Asset Disposal Income	--	5,800	--	46,700	--	--	--	--	28,500	--	--	--
Asset Impairment Loss	-649,800	12.1M	2.2M	2.1M	2.4M	1.0M	496,800	2.3M	1.7M	44,100	1.5M	26,600
Other Income	5.1M	4.0M	4.8M	2.1M	3.2M	2.5M	3.8M	963,500	--	--	--	--
Income Before Tax	3.5M	36.8M	72.9M	86.2M	55.2M	52.0M	11.4M	14.9M	15.5M	8.4M	15.9M	2.9M
Income Tax	-13.5M	-856,500	5.7M	12.7M	6.5M	4.8M	2.2M	2.7M	2.0M	2.2M	2.0M	388,900
+Net Income	17.1M	37.6M	67.2M	73.6M	48.7M	47.3M	9.2M	12.2M	13.5M	6.2M	13.9M	2.5M
Net Margin %	3.1%	7.7%	14.0%	16.4%	17.2%	19.3%	7.3%	9.3%	12.6%	8.2%	17.9%	7.5%
Net Income Attributable	17.1M	37.6M	67.2M	73.6M	48.7M	47.3M	9.2M	12.2M	13.5M	6.2M	13.9M	2.5M
Eps Basic	0.12	0.27	0.79	1.28	0.86	0.85	0.17	0.22	0.27	0.12	0.66	0.23
Eps Diluted	0.12	0.27	0.79	1.28	0.86	0.85	0.17	0.22	0.27	0.12	0.45	--

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
Cash And Equivalents	84.5M	204.0M	764.0M	108.0M	111.0M	33.9M	23.3M	11.0M	22.7M	10.4M	12.8M	10.2M
Trading Financial Assets	252.0M	341.0M	10.6M	397,700	--	49.8M	--	--	--	--	--	--
Accounts Receivable	98.6M	85.5M	82.0M	88.6M	41.7M	56.0M	21.5M	24.6M	22.9M	16.6M	12.2M	10.1M
Notes Receivable	1.1M	715,000	1.3M	142,500	33,400	784,300	2.3M	2.6M	100,000	12,600	--	182,400
Notes And Accounts Receivable	99.8M	86.2M	83.3M	88.7M	41.7M	56.7M	23.7M	27.2M	23.0M	16.6M	12.2M	10.3M
Prepayments	2.4M	2.4M	2.6M	2.2M	1.3M	3.4M	2.0M	554,700	2.4M	41,800	319,500	773,600
Inventory	69.0M	61.4M	51.1M	46.8M	61.0M	36.4M	21.9M	22.9M	21.5M	22.7M	17.0M	12.2M
Total Current Assets	554.0M	731.0M	937.0M	277.0M	232.0M	187.0M	107.0M	119.0M	73.2M	56.7M	52.3M	37.0M
Long Term Equity Investment	--	--	--	1.9M	1.6M	1.6M	1.2M	1.1M	--	--	--	--
Fixed Assets	--	188.0M	143.0M	110.0M	88.4M	74.8M	65.8M	64.7M	49.1M	49.3M	46.6M	47.2M
Fixed Assets Total	199.0M	188.0M	143.0M	110.0M	88.4M	74.8M	65.8M	64.7M	49.1M	49.3M	46.6M	47.2M
Construction In Progress	--	200.0M	27.4M	24.6M	1.8M	67,900	170,000	--	5.3M	5.5M	5.7M	2.0M
Construction In Progress Total	1.4M	200.0M	27.4M	24.8M	1.9M	67,900	170,000	--	5.3M	5.5M	5.7M	2.0M
Intangible Assets	8.5M	8.7M	8.2M	7.9M	8.1M	8.4M	8.3M	8.4M	8.4M	8.6M	8.8M	9.0M
Long Term Deferred Expenses	319.0M	155.0M	71.1M	50.6M	15.0M	14.5M	6.1M	8.2M	6.8M	6.1M	1.6M	2.2M
Total Non Current Assets	762.0M	756.0M	365.0M	281.0M	118.0M	101.0M	83.2M	82.8M	69.6M	69.5M	62.7M	62.0M
Total Assets	1.3B	1.5B	1.3B	558.0M	350.0M	288.0M	190.0M	202.0M	143.0M	126.0M	115.0M	99.0M
Short Term Borrowings	10.0M	15.9M	10.0M	22.3M	22.7M	25.6M	17.1M	20.5M	32.7M	32.8M	30.0M	31.0M
Accounts Payable	46.9M	106.0M	30.1M	36.5M	20.7M	25.3M	9.4M	16.4M	9.4M	4.0M	3.6M	2.2M
Advance Receipts	2.0M	2.0M	1.2M	729,600	--	2.1M	1.8M	149,400	59,900	429,000	115,200	202,000
Contract Liabilities	3.1M	2.2M	1.3M	6.3M	2.2M	--	--	--	--	--	--	--
Total Current Liabilities	125.0M	191.0M	101.0M	129.0M	83.4M	87.0M	37.7M	48.4M	49.1M	45.9M	40.9M	38.3M
Total Non Current Liabilities	158.0M	178.0M	87.5M	80.7M	3.6M	1.1M	379,900	828,600	--	--	--	560,000
Total Liabilities	284.0M	370.0M	188.0M	209.0M	87.0M	88.2M	38.1M	49.3M	49.1M	45.9M	40.9M	38.9M
Paid In Capital	140.0M	108.0M	76.9M	57.6M	57.6M	55.6M	55.6M	55.6M	50.0M	50.0M	21.1M	21.1M
Capital Reserve	767.0M	799.0M	824.0M	146.0M	135.0M	64.7M	64.7M	64.0M	18.0M	18.0M	29.2M	29.2M
Surplus Reserve	29.8M	24.9M	19.9M	15.5M	9.6M	7.2M	4.1M	2.7M	1.5M	249,900	1.1M	952,300
Retained Earnings	149.0M	186.0M	192.0M	129.0M	60.8M	72.2M	28.0M	30.3M	24.3M	12.1M	22.6M	8.8M
Equity Attributable	1.0B	1.1B	1.1B	348.0M	263.0M	200.0M	152.0M	152.0M	93.8M	80.3M	74.1M	60.1M
Total Equity	1.0B	1.1B	1.1B	348.0M	263.0M	200.0M	152.0M	152.0M	93.8M	80.3M	74.1M	60.1M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
Cash From Sales	493.0M	469.0M	474.0M	396.0M	290.0M	217.0M	128.0M	122.0M	104.0M	73.9M	82.3M	30.5M
Tax Refunds Received	5.5M	10.3M	16.8M	912,500	9.4M	3.4M	2.8M	1.6M	--	25,200	331,300	656,000
Total Operating Cash Inflow	539.0M	500.0M	511.0M	417.0M	314.0M	224.0M	135.0M	125.0M	134.0M	97.8M	114.0M	68.9M
Cash Paid For Goods	162.0M	129.0M	141.0M	116.0M	117.0M	77.7M	34.2M	27.5M	32.7M	24.4M	28.7M	4.7M
Cash Paid To Employees	242.0M	236.0M	204.0M	148.0M	88.1M	66.2M	55.4M	46.4M	32.1M	31.2M	19.8M	17.0M
Taxes Paid	10.7M	7.8M	12.3M	12.1M	8.2M	7.7M	4.5M	5.2M	4.2M	3.7M	1.9M	14,100
Total Operating Cash Outflow	458.0M	480.0M	412.0M	312.0M	260.0M	184.0M	113.0M	97.5M	112.0M	99.0M	90.6M	61.9M
Operating Cash Flow	80.9M	20.9M	99.3M	105.0M	54.5M	40.7M	21.8M	27.8M	22.1M	-1.2M	23.0M	7.0M
Total Investing Cash Inflow	623.0M	1.2B	84.0M	1.9M	256.0M	248.0M	322.0M	52.0M	133,000	79.0M	--	2.6M
Total Investing Cash Outflow	668.0M	1.8B	216.0M	92.1M	238.0M	296.0M	317.0M	127.0M	8.0M	80.6M	16.7M	627,000
Investing Cash Flow	-44.8M	-582.0M	-132.0M	-90.3M	17.9M	-48.9M	5.4M	-74.9M	-7.9M	-1.6M	-16.7M	2.0M
Cash From Borrowings	19.7M	15.9M	12.2M	26.2M	57.5M	41.1M	25.6M	30.1M	36.6M	35.3M	34.0M	1.0M
Dividends And Interest Paid	49.3M	38.8M	783,700	782,200	58.9M	1.2M	11.3M	1.5M	2.5M	2.4M	2.7M	168,900
Debt Repayments	25.6M	10.0M	24.6M	26.6M	60.4M	32.7M	29.0M	42.2M	36.7M	32.5M	35.0M	2.5M
Total Financing Cash Inflow	19.7M	15.9M	722.0M	26.2M	123.0M	41.1M	33.6M	83.1M	36.6M	35.3M	34.0M	1.0M
Total Financing Cash Outflow	157.0M	72.1M	39.6M	36.7M	119.0M	33.9M	48.3M	47.3M	39.1M	34.9M	37.6M	4.8M
Financing Cash Flow	-138.0M	-56.2M	683.0M	-10.5M	4.2M	7.3M	-14.7M	35.8M	-2.6M	395,400	-3.7M	-3.8M
Net Change In Cash	-96.7M	-618.0M	658.0M	2.3M	70.5M	-316,500	12.3M	-11.7M	12.3M	-2.4M	2.6M	5.1M
Ending Cash Balance	38.7M	135.0M	754.0M	95.8M	93.5M	23.0M	23.3M	11.0M	22.7M	10.4M	12.8M	10.2M
Capex	109.0M	248.0M	124.0M	92.1M	33.5M	33.9M	16.3M	20.9M	8.0M	12.8M	8.7M	627,000